Biological concepts in recurrent Plasmodium vivax malaria
- PMID:29564998
- DOI: 10.1017/S003118201800032X
Biological concepts in recurrent Plasmodium vivax malaria
Abstract
A curious aspect of the evolution of the hypnozoite theory of malarial relapse is its transmogrification from theory into 'fact', this being of historical, linguistic, scientific and sociological interest. As far as it goes, the hypnozoite explanation for relapse is almost certainly correct. I contend, however, that many of the genotypically homologous, non-reinfection, relapse-like Plasmodium vivax recurrences that researchers ascribe to hypnozoite activation are probably hypnozoite-independent. Indeed, some malariologists are starting to recognize that homologous P. vivax recurrences have most likely been overattributed to activation of hypnozoites. Hitherto identified, non-hypnozoite, possible plasmodial sources of recurrence that must be considered, besides circulating erythrocytic stages, include parasites in splenic dendritic cells, other cells in the spleen (in addition to infected erythrocytes there), bone marrow (importantly) and the skin. I argue that we need to take into account the possibility of a dual or multiple extra-vascular origin of P. vivax non-reinfection recurrences, not arbitrarily discount it. The existence of a P. vivax reservoir(s) is a topical subject and one of practical importance for malaria eradication. Pertinent drug-associated matters are also discussed, as is the dormancy-related significance of clues provided by blood-stage-induced malarial infection.
Keywords: Bone marrow; Plasmodium cynomolgi; Plasmodium vivax; hypnozoite; malaria; primaquine; recrudescence; recurrence; relapse; spleen.
Similar articles
- Malaria Eradication and the Hidden Parasite Reservoir.Markus MB.Markus MB.Trends Parasitol. 2017 Jul;33(7):492-495. doi: 10.1016/j.pt.2017.03.002. Epub 2017 Mar 30.Trends Parasitol. 2017.PMID:28366603
- Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.White MT, Karl S, Battle KE, Hay SI, Mueller I, Ghani AC.White MT, et al.Elife. 2014 Nov 18;3:e04692. doi: 10.7554/eLife.04692.Elife. 2014.PMID:25406065Free PMC article.
- New Evidence for Hypnozoite-Independent Plasmodium vivax Malarial Recurrences.Markus MB.Markus MB.Trends Parasitol. 2018 Dec;34(12):1015-1016. doi: 10.1016/j.pt.2018.08.010. Epub 2018 Sep 10.Trends Parasitol. 2018.PMID:30213708
- Plasmodium vivax Latent Liver Stage Infection and Relapse: Biological Insights and New Experimental Tools.Schäfer C, Zanghi G, Vaughan AM, Kappe SHI.Schäfer C, et al.Annu Rev Microbiol. 2021 Oct 8;75:87-106. doi: 10.1146/annurev-micro-032421-061155. Epub 2021 Jul 1.Annu Rev Microbiol. 2021.PMID:34196569Review.
- Clinical implications of a gradual dormancy concept in malaria.Richter J, Franken G, Holtfreter MC, Walter S, Labisch A, Mehlhorn H.Richter J, et al.Parasitol Res. 2016 Jun;115(6):2139-48. doi: 10.1007/s00436-016-5043-0. Epub 2016 Apr 15.Parasitol Res. 2016.PMID:27079460Review.
Cited by
- Safety and Efficacy of Tafenoquine forPlasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives.Markus MB.Markus MB.Ther Clin Risk Manag. 2021 Sep 8;17:989-999. doi: 10.2147/TCRM.S269336. eCollection 2021.Ther Clin Risk Manag. 2021.PMID:34526770Free PMC article.
- Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares IS, de Brito CFA, Carvalho LH, Sousa TN.Silvino ACR, et al.Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02056-19. doi: 10.1128/AAC.02056-19. Print 2020 Apr 21.Antimicrob Agents Chemother. 2020.PMID:32122891Free PMC article.
- High Proportion of Genome-Wide Homology and Increased Pretreatmentpvcrt Levels in Plasmodium vivax Late Recurrences: a Chloroquine Therapeutic Efficacy Study.Rovira-Vallbona E, Van Hong N, Kattenberg JH, Huan RM, Binh NTH, Ngọc NTH, Guetens P, Hieu NL, Hien NTT, Sang VT, Long ND, Sauve E, Duong TT, Xa NX, Erhart A, Rosanas-Urgell A.Rovira-Vallbona E, et al.Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0009521. doi: 10.1128/AAC.00095-21. Epub 2021 Jul 16.Antimicrob Agents Chemother. 2021.PMID:34031050Free PMC article.
- Theoretical origin of genetically homologousPlasmodium vivax malarial recurrences.Markus MB.Markus MB.S Afr J Infect Dis. 2022 Mar 30;37(1):369. doi: 10.4102/sajid.v37i1.369. eCollection 2022.S Afr J Infect Dis. 2022.PMID:35399558Free PMC article.
- Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype.Hommel B, Sturny-Leclère A, Volant S, Veluppillai N, Duchateau M, Yu CH, Hourdel V, Varet H, Matondo M, Perfect JR, Casadevall A, Dromer F, Alanio A.Hommel B, et al.PLoS Pathog. 2019 Jul 29;15(7):e1007945. doi: 10.1371/journal.ppat.1007945. eCollection 2019 Jul.PLoS Pathog. 2019.PMID:31356623Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials